Navigation Links
The Acute Liver Failure Study Group Initiates Phase 2a Study of OCR-002 for Treatment of Acute Liver Failure after Acetaminophen Overdose
Date:11/8/2012

SAN DIEGO, Nov. 8, 2012 /PRNewswire/ -- Ocera Therapeutics, Inc. announced that the first patient has enrolled in a Phase 2a study to evaluate the safety and tolerability of OCR-002 (ornithine phenylacetate) in the treatment of patients with acute liver injury (ALI) as well as those that have progressed to acute liver failure (ALF) following acetaminophen overdose.

OCR-002 is an investigational drug designed to directly reduce circulating blood levels of ammonia which, at high levels, is neurotoxic, associated with brain injury, and may lead to hepatic encephalopathy and mortality. The investigator-sponsored study, referred to as STOP-ALF, is being conducted by The Acute Liver Failure Study Group, a National Institutes of Health-funded consortium led by UT Southwestern Medical Center.

"When a patient presents with acute liver failure, physicians have no medicines available that can directly lower circulating levels of ammonia, which drive hepatic encephalopathy and can lead to coma and death," stated William M. Lee, M.D., Lead Investigator, and Professor, Internal Medicine, UT Southwestern.  "OCR-002 acts specifically by scavenging for and removing ammonia from the blood, which may prevent the development of hepatic encephalopathy in patients at risk. Our collaboration to study OCR-002 is a key step towards understanding more about a potentially lifesaving drug."

The STOP-ALF study is a Phase 2a multi-center, open-label study that will enroll 24 participants with severe acute liver injury or acute liver failure. The primary endpoint will be safety and tolerability. Secondary endpoints include measurement of OCR-002 plasma concentration, change in venous ammonia and neurological function.

Hepatic encephalopathy is an often-reversible neuropsychiatric abnormality observed in patients with acute liver failure; it is marked by a worsening of brain function when the liver is no longer able to remove toxic substances such as ammo
'/>"/>

SOURCE Ocera Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
2. CoLucid Pharmaceuticals Details Phase 3 Development Strategy for Lasmiditan to Address Major Unmet Needs in Acute Migraine Therapy
3. Significant Pre-Clinical Data in Acute Lung Injury
4. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
5. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
6. Vibra Healthcare Announces Agreement To Manage Two Acute Rehabilitation Hospitals
7. Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
8. Cell Therapeutics to Host Investor and Analyst Meeting to Discuss Targeted Agents in Myelofibrosis and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia on Sunday, June 3, 2012, in Chicago
9. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
10. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
11. AXIOS™ Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 UBM Medica ... – a new online community and information resource for ... manage and treat their patients with neurological disorders ... with an aging population, necessitates greater access to dedicated ...  Key statistics on neurological conditions include: , ...
(Date:7/23/2014)... Calif. , July 23, 2014 Pharmavite ... the company,s chief customer officer effective immediately. Toll recently ... customer sales and marketing, category management, private label and ... . In his new global role, Toll will expand ... global sales planning. "Toll,s appointment to chief ...
(Date:7/23/2014)... Research and Markets   has ... Ablation Catheters Market 2014-2018" report to their ... Catheter ablation is a minimally invasive ... pathways from sections of the heart that promote ... Cardiac arrhythmias can be of several types, including ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3
... 2011 Amgen (NASDAQ: AMGN ) reported total ... to $3,959 million versus $3,804 million in the second quarter ... second quarter of 2011 to $3,893 million versus $3,613 million ... revenue in the second quarter of 2011 included a decline ...
... ENCINITAS, Calif., July 28, 2011 /PRNewswire-iReach/ -- Encinitas, CA-based ... the 2011 season in full focus with today,s launch of their ... E N invites the World Wide Web to explore art, culture, ...   http://photos.prnewswire.com/prnh/20110728/CG43745 ) THE LOOK ...
Cached Medicine Technology:Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 2Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 3Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 4Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 5Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 6Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 7Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 8Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 9Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 10Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 11Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 12Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 13Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 14Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 15Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 16Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 17Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 18Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion 19R A E N Optics Launches New Website and Releases New Styles 2
(Date:7/24/2014)... TORONTO, ON (PRWEB) July 24, 2014 ... a new survey conducted in partnership with AIIM, ... industries. The most surprising insight of the survey ... to archive outbound customer correspondence for customer service, ... needs, only 44% of organizations save exact facsimiles ...
(Date:7/24/2014)... NJ (PRWEB) July 24, 2014 Losing a ... – overwhelming sadness as well as shock, fear, guilt, anger, ... spouse's death agonizing and confusing. It may be small comfort ... temporary but it is in fact the case that grieving ... says clinical psychologist Dr. Hayley Hirschmann of ...
(Date:7/24/2014)... 2014 Professional Healthcare at Home, an affiliate ... Schulkin, a nurse with the company’s Pleasant Hill, CA, home ... for the 2014 Home Care & Hospice Nurse of the ... & Hospice (NAHC). , Annually, NAHC promotes a nationwide ... to help choose a top home care and hospice nurse ...
(Date:7/24/2014)... Boston, MA (PRWEB) July 24, 2014 ... certification as a Woman-Owned Small Business (WOSB) by the ... is an SBA -approved third party certifier. ... management consultancy that collaborates with clients to drive growth ... assists with both developing insights and activating options through ...
(Date:7/24/2014)... AZ (PRWEB) July 24, 2014 Colleen’s ... has donated $10,000 to Johns Hopkins Medicine to fund ... Billy Cundiff. , According to Cundiff, this is the ... supported ovarian cancer research at Johns Hopkins Medicine. , ... is to work with promising young investigators at some ...
Breaking Medicine News(10 mins):Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 2Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 3Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 4Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 2Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 3Health News:Imbue Partners Certified as Woman-Owned Small Business 2Health News:Colleen’s Dream Foundation Donates $10,000 to Johns Hopkins Medicine for Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Donates $10,000 to Johns Hopkins Medicine for Ovarian Cancer Research 3
... of cancer drugs can be used effectively while ... is closely monitored and controlled, a clinical panel ... and hypertension experts together to draft new recommendations ... of cancer. First approved in the mid-2000,s, these ...
... those surveyed were ,OK either way, , TUESDAY, May 11 ... childbearing age fall into one of two categories: They are ... children. , But a new national survey suggests there,s a ... women aged 25 to 45 who were polled said they ...
... ... Member Take Championship Title , ... (PRWEB) -- Human Touch ®, the U.S. market leader of innovative massage chairs, Perfect ... PGA Pro Tim Clark for his first PGA TOUR victory in his career at ...
... ... the ‘Real Housewives of New York City’, for emphasizing the importance of choosing a ... reality show. , ... New York (Vocus) May 11, 2010 -- The American Society for Aesthetic Plastic ...
... benefits seen in healthy volunteers, researchers say , TUESDAY, May ... new study shows. , German researchers tested pain responses in ... China more than 2,000 years ago, increased pain thresholds by ... treated leg and untreated (contralateral) leg. , The study also ...
... ... , ... 11, 2010 -- Richard Marbes, Chairman of the Disabled American Veterans (DAV) Charitable Services Trust ... pleased to advise that favorable consideration was given to the funding request for USA Cares ...
Cached Medicine News:Health News:Monitoring and control can limit side effects of promising cancer drugs 2Health News:Monitoring and control can limit side effects of promising cancer drugs 3Health News:Some Women Lack Strong Feelings About Motherhood 2Health News:Human Touch Brand Ambassador and PGA Pro Tim Clark Wins First PGA TOUR Victory at PLAYERS Championship 2Health News:Human Touch Brand Ambassador and PGA Pro Tim Clark Wins First PGA TOUR Victory at PLAYERS Championship 3Health News:The Real Housewives of New York City Know What Questions to Ask When Looking for a Plastic Surgeon 2Health News:The Real Housewives of New York City Know What Questions to Ask When Looking for a Plastic Surgeon 3Health News:The Real Housewives of New York City Know What Questions to Ask When Looking for a Plastic Surgeon 4Health News:Disabled American Veterans Charitable Services Trust Supports OIF/OEF Veterans Battling PTSD 2
... Combines BchiVac V-500 and water-cooled secondary condenser ... is a powerful PTFE membrane vacuum pump ... Applications Ideally suited for use ... Laboratory vacuum source for instruments including ...
... UVS400 is a multi-tasking vacuum source and ... refrigerated vapor trap and a maintenance-free, oil-free ... The easy-to-use, wide-mouth glass condensation flask collects ... for easy disposal. The UVS400 provides an ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
... with Vacuum Controller V-800 Efficiently controls vacuum ... on and off as needed to maintain preset vacuum ... is a powerful PTFE membrane vacuum pump designed to ... suited for use with up to two rotary evaporators ...
Medicine Products: